Document:

Exhibit 10.3

 

PATENT LICENSE AGREEMENT

 

This Patent License Agreement (“Agreement”) is
made this 30 day of November, 2017 (“Agreement Date”), by and between Wilson Electronics, LLC, a limited
liability company existing under the laws of the State of Delaware, having its principal place of business at 3301 E. Deseret
Drive, St. George, Utah 84790 (“Wilson”); and Signifi Mobile, Inc. a corporation organized and existing
under the laws of Ontario, Canada, having its principal place of business at 1001 Rue Lenoir, Suite A-414, Montreal, Quebec,
H4C2Z6, Canada (“Licensee”). Where appropriate, Wilson and. Licensee shall hereinafter be referred to
collectively as “Parties” and individually as a “Party”.

 

WHEREAS Wilson owns, controls
or is otherwise entitled to grant rights under certain patents and patent applications relating to Licensed Products (as hereinafter
defined) and Licensee manufactures, sells and distributes certain Licensed Products;

 

WHEREAS Licensee markets and
sells Licensed Products that are directly competitive with products marketed and sold by Wilson; and

 

WHEREAS Wilson is willing to
grant a license and Licensee is willing to obtain a license under the Licensed Patents on the terms and conditions set forth in
this Agreement.

 

NOW THEREFORE, in consideration
of the premises and mutual covenants herein contained, the Parties hereby agree as follows:

 

		1.	Definitions

 

The following capitalized
terms used in this Agreement shall have the respective meanings ascribed to them below in this Section unless otherwise expressly
defined in this Agreement.

 

		1.1	“Affiliate” of an entity means an entity
that at any time controls, is controlled by, or is under common control with such entity.. Such entities shall only be deemed
to be Affiliates hereunder for as long as such control exists. Control, in this context, exists where one entity owns more than
20% whether directly or indirectly of the right to exercise voting power with respect to the election of directors or similar
managing authority of an entity (whether through direct or indirect beneficial ownership of shares or securities of such entity
or otherwise) or, if the entity in question does not have outstanding voting shares or securities, more than 20% of the equity
interest in such entity.

 

		1.2.	“Auditor” has the meaning set forth
in Section 5.2.

 

		1.3.	“Average Selling Price” of a specific
model or type of Licensed Product means the average selling price charged by Licensee and its Affiliates for all such Licensed
Product during the immediately preceding calendar quarter.

 

		1.4.	“Confidential Information” has the meaning
set forth in Section 10.1.

 

    	CONFIDENTIAL	Page 1

     

    

 

		1.5.	“Effective
                                         Date” means January 1, 2018.

 

		1.6.	“End
                                         User Device” means a stand-alone cell phone radio signal booster having as its
                                         primary function to receive and amplify digital cellular 2G, 3G and/or 4G, 5G, etc.,
                                         radio signals and which is designed for use in home, office or civilian ground-based
                                         vehicular environments. End User Devices exclude all other products and applications,
                                         including, without limitation, any chip-based radio signal booster that is intended to
                                         constitute a component of a larger device or product, such as a smart phone, tablet,
                                         game player, laptop computer or vehicle.

 

		1.7.	“Have
                                         Made” means the right to have a Third Party make Licensed Products for the use
                                         and benefit of the Licensee and its Affiliates when (a) the Licensed Products are made
                                         under contract by a Third Party manufacturer for Licensee or its Affiliates and are units
                                         supplied by such Third Party manufacturer solely to Licensee or its Affiliates (or directly
                                         to their customers on behalf of Licensee or its Affiliates) and to no other Third Party;
                                         and (b) such Licensed Products are not re-Sold back to, or on behalf of, such Third Party
                                         manufacturers or its Affiliates.

 

		1.8.	“Wilson
                                         Licensed Patents” shall mean all Patents throughout the Territory owned, controlled
                                         or licensable (without the obligation to pay any Third Party) by Wilson or its Affiliates,
                                         the practice of which is necessary to implement either a mandatory or optional portion
                                         of a normative clause of the Standard when, at the time of the Standard’s approval, there
                                         was no commercially and technically feasible non-infringing alternative implementation
                                         method for such mandatory or optional portion of the normative clause. The term Wilson
                                         Licensed Patents shall also mean certain Patents throughout the Territory owned, controlled
                                         or licensable (without the obligation to pay any Third Party) by Wilson or its Affiliates
                                         that are not necessary to implement the Standard, but which Wilson is willing to license
                                         to Licensee. For the avoidance of doubt, the Wilson Licensed Patents include those Patents
                                         listed in Appendix A hereto and the existing and future patent priority related
                                         family members that provide priority date to or derive a priority date from a Patent
                                         listed in Appendix A, and all foreign counterparts thereof throughout the Territory.

 

		1.9.	“Licensed
                                         Product” means an End User Device that is branded primarily with a brand owned
                                         by or licensed to Licensee and/or its Affiliates, A list of Licensees anticipated Licensed
                                         Products by name and SKU is provided in Exhibit B which shall be updated by Licensee
                                         in January and July of each year for the duration of the Term.

 

		1.10.	“Net
                                         Selling Price” shall mean the Selling Price of a Licensed Product, less sales
                                         tax, import tax, export tax and other taxes and/or customs duties levied or imposed directly
                                         upon the Sale of such Licensed Products and collected by Licensee.

 

    	CONFIDENTIAL	Page 2

     

    

 

		1.11. 	“Patent”
                                         shall mean patent claims (including claims of licensable patent applications, whether
                                         or not divisionals, continuations, continuations-in-part, reissues, renewals, or extensions
                                         therefor and any counterparts claiming priority therefrom), and like statutory rights
                                         other than design patents.

 

		1.12.	“Royalty”
                                         has the meaning set forth in Section 3.2.

 

		1.13.	“Sale”,
                                         “Sell” or “Sold” or any similar variation of such term,
                                         means the delivery of Licensed Products in the Territory to a Third Party for compensation,
                                         including lease, rent or similar transaction, or the putting into use of the Licensed
                                         Products by the Licensee and/or its Affiliates and/or End-Users for any purpose other
                                         than routine testing, quality control or certification, with a Sale being deemed to have
                                         occurred upon invoicing or putting into use, whichever shall first occur.

 

		1.14.	“Selling
                                         Price” shall mean with respect to each Licensed Product Sold by Licensee or
                                         any of its Affiliates, one of the following, whichever is applicable:

 

	 	(a)	With respect to Sales to an entity that is not an Affiliate of Licensee, the Selling Price will be the selling price charged by Licensee or its Affiliate to such unrelated buyer.

 

	 	(b)	With respect to Sales to an entity that is an Affiliate of Licensee, the Selling Price will be (a) the selling price charged by the final vendee Affiliate to a non-Affiliate buyer of such Licensed Product, or (b) if no further Sale of such Licensee Product is made by the Affiliate to a non-Affiliate, then the Selling Price for each such Licensed Product shall be the Average Selling Price of the Licensed Product.

 

	 	(c)	In the event that a Licensed Product is Sold to a non-Affiliate as part of a combination or bundle including both Licensed Products arid other products (e.g., an End User Device sold together with a smart phone or wireless router), the Selling Price of the Licensed Product shall be, at Licensee’s sole discretion, either the Net Sales Price of the combination or bundle, or the greater of (x) the Average Selling Price: of such Licensed Product, and (y) the portion of the aggregate sale price of such combination or bundle which is allocable to the Licensed Product using reasonable and standard accounting practices in the. industry.

 

		1.15.	“Standard” means FCC Part 20 §20.21(e).

 

		1.16.	“Term” has the meaning set forth in
Section 5.1.

 

		1.17.	“Territory” means world-wide.

 

		1.18.	“Third Party” means any entity that
is not a Party or an Affiliate of a Party.

 

    	CONFIDENTIAL	Page 3

     

    

 

		2.	Licenses

 

		2.1.	License Grant by Wilson. Wilson, hereby grants
to Licensee an irrevocable (except upon Termination for Material Breach), non-exclusive, nontransferable (except as expressly
provided herein), royalty-bearing license under the Wilson Licensed Patents in the Territory during the Term to make, Have Made,
use, import, Sell and offer for Sale Licensed Products.

 

		2.2.	Limitations. The foregoing license does not include
any right or license to manufacture or sell products that are based on a Third Party design and which are sold by Licensee or
its Affiliates to or on behalf of such Third Party as the Third Party’s own product and not a Licensed Product.

 

		2.3.	Sublicenses. The licenses granted under this Article
2 shall include the right of Licensee to grant sublicenses to its Affiliates. No such sublicense shall be broader in any respect
than the license held by Licensee. Any sublicensed Affiliate will be bound in all respects to all of the obligations of Licensee
contained in this Agreement and Licensee shall be responsible for compliance by its sublicensed Affiliates with such obligations
and jointly and severally liable with such Affiliates for all actions and omissions of such Affiliates. Any sublicense granted
hereunder shall indicate that Wilson is a third party beneficiary and entitled to enforce the terms and conditions of the sublicense.
Licensee shall enforce all sublicenses at its costs and shall be responsible for the acts and omissions of its sublicensees with
respect to such sublicenses. Any sublicense granted under this Agreement shall immediately terminate when an Affiliate ceases
to be an Affiliate of Licensee and otherwise upon termination of this Agreement

 

		2.4.	Licensee Liability. Notwithstanding any sublicense
agreement, Licensee shall remain primarily liable to Licensor for all of Licensee’s duties and obligations contained in this Agreement,
including the payment of all Royalties. Any act or omission of a sublicensee that would be a breach of this Agreement if committed
or omitted by Licensee will be a breach by Licensee. Each sublicense agreement shall contain a right of termination by Licensee
for the sublicensee’s: (a) breach of any payment or reporting obligations affecting Wilson; or (b) breach of any other terms or
conditions of the sublicense agreement that is also set forth, in substance, in this Agreement, which breach would constitute
a breach of this Agreement if Licensee failed to comply therewith.

 

		2.5.	Reservation of Rights. All rights not expressly
granted, herein are expressly reserved. Nothing in this Agreement shall be construed as conveying, whether explicitly, by implied
license, or otherwise, any license rights not explicitly granted herein. Nothing in this Agreement shall be construed as conveying,
whether explicitly, by implied license, or otherwise, any rights to any Third Party user or purchaser of the Licensed Products,
under any Licensed Patent covering any combination of the Licensed Products with any other product (not licensed hereunder) where
the patent claim is infringed by the combination and not by the Licensed Product alone.

 

    	CONFIDENTIAL	Page 4

     

    

 

		2.6.	Marking. Licensee shall mark all Licensed Products
manufactured, used or sold under this Agreement as agreed by the Parties using a Licensee website used to promote and educate
end users about the Licensed Products in order to preserve Wilson’s rights under and comply with applicable laws.

 

		2.7.	Voluntary Standard. Nothing in this Agreement
shall be construed as a requirement that Licensee or its Affiliates implement or adopt the Standard or any other standard in any
product or refrain from engaging in any competitive activity or promotion of any competitive standard.

 

		2.8.	Acknowledgement. Licensee understands that the
licenses granted hereunder with respect to certain of the Wilson Licensed Patents have been granted in connection with Wilson’s
commitment, contained in a Letter of Assurance submitted to IEEE on June 8, 2015, to grant such licenses under reasonable rates
and other reasonable terms and conditions. Licensee hereby acknowledges that the Royalties and other terms and conditions of this
Agreement are reasonable and fairly reflect the value that Licensee will obtain from the licenses and other rights granted hereunder,
that Licensee has willingly entered into this Agreement without coercion or other pressure from Wilson, and that Wilson has fully,
and in good faith, complied with any commitment it may or may not have to grant a license under the Wilson Licensed Patents to
Licensee on reasonable terms. Accordingly, Licensee hereby releases and waives any claim that it may have under contract, antitrust,
competition, estoppel, or any other legal or equitable theory with respect to any commitment Wilson may or may not have to grant
a license under the Wilson Licensed Patents to Licensee on reasonable terms.

 

		2.9.	Return License to Wilson. Licensee agrees that if, as of the Effective Date, Licensee
                                                                                   owns, controls or is otherwise entitled to grant rights under any Patents throughout the Territory owned, controlled or
                                                                                   licensable (without the obligation to pay any Third Party) by Licensee or its current Affiliates as of the Effective Date,
                                                                                   the practice of which is necessary to implement either a mandatory or optional portion of a normative clause of the Standard,
                                                                                   Licensee hereby grants to Wilson a non-exclusive, non-transferable, non-royalty-bearing license in the Territory during the
                                                                                   Term to make, Have Made, use, import, Sell and offer for Sale products pursuant to any such Patents.

 

		3.	Payment

 

		3.1.	Royalties.
                                         Licensee shall pay to Wilson a running royalty equal to four and one half percent
                                         (4.5%) of the Net Selling Price of each Licensed Product Sold by Licensee or its Affiliates
                                         in the Territory during the Term (the “Royalty”). Royalties shall be
                                         due and payable hereunder on a quarterly basis with respect to all Sales of Licensed
                                         Products during a calendar quarter no later than forty-five (45) days following the end
                                         of each calendar quarter during the Term.

 

    	CONFIDENTIAL	Page 5

     

    

 

		3.2.	Remittance Details. All payments hereunder shall
be made by wire transfer in U.S. Dollars to the following bank account of Wilson, or as may be otherwise notified by Wilson to
Licensee in writing at least ten (10) days prior to the due date of any such payment:

 

Wilson Electronics, LLC

Acct # 039013297

Routing # 124000054

S.W.I.F.T. Code: ZFNBUS55

Zions Bank

One South Main Street

Salt Lake City, Utah 84133

 

		3.3.	Quarterly Reporting.
                                         Licensee, on behalf of itself and its Affiliates, shall submit to Wilson a written
                                         report (“Sales Report”) within forty-five (45) days of the end of
                                         each calendar quarter during the Term. Each Such Sales Report shall list each type or
                                         model of Licensed Products Sold and the aggregated Net Selling Price for the total of
                                         all of Licensed Product Sold by Licensee and its Affiliates during such calendar quarter.
                                         Licensee warrants that each such Sales Report shall be complete and accurate and shall
                                         be certified by a duly authorized financial officer of Licensee.

 

		3.4.	Taxes. All payments required by this Agreement
are exclusive of taxes, customs or any other duties, and Licensee agrees to bear and be responsible for the payment of all such
taxes, customs or other duties including, but not limited to, all sales, use, rental receipt, personal property or other taxes
and their equivalents which may be levied or assessed in connection with this Agreement (excluding only taxes based on Wilson’s
net income).

 

		3.5.	Currency Conversion. For any currency conversion
from the currency of one country in which the Licensed Products are sold into U.S. Dollars required in determining the royalties
due hereunder, such conversion shall be calculated at the conversion rate as reported in the Wall Street. Journal (New
York Edition) on the last business day of the applicable quarterly period in which the royalties are determined, or such other
method agreed to by the Parties in writing.

 

		3.6.	Overdue Amounts. All overdue amounts hereunder
shall bear interest at an annual rate of ten percent (10%). Such interest shall commence on the date such payment becomes due
until such payment is made. If at any time such interest rate exceeds the maximum legal rate in the jurisdiction where a claim
therefore is being asserted, the interest rate shall be reduced to such maximum legal rate.

 

    	CONFIDENTIAL	Page 6

     

    

 

		4.	Records and Audit

 

		4.1.	Recordkeeping. Licensee shall, and shall cause
its Affiliates to, keep accurate and complete books and records which relate to the Licensed Products in sufficient detail (consistent
with generally accepted accounting practices for the industry) to enable the Royalties payable hereunder to be determined. Such
books and records, shall be kept by Licensee for a period of three (3) years after the calendar quarter to which the books and
records apply.

 

		4.2.	Audit.
                                         Wilson shall have the right during the Term and for two (2) years thereafter, upon at
                                         least thirty (30) days’ notice, to appoint, at its own expense, a Third Party independent
                                         auditor (“Auditor”) to examine and audit any and all books and records
                                         of Licensee and its Affiliates to the extent relevant to the determination of Royalties
                                         payable hereunder and Licensee’s and its Affiliates’ compliance with this
                                         Agreement. The audit shall be conducted during Licensee’s normal business hours
                                         and without undue interference with Licensee’s normal business. Any such audit
                                         shall take place no more than once per calendar year, and any particular calendar quarter
                                         shall be audited only once. Licensee shall assemble in a single location, or otherwise
                                         make available in electronic form, all books and records necessary for such audit to
                                         be carried out, and shall make such personnel available as may be reasonably necessary
                                         to respond to any inquiries by the Auditor. The Auditor shall sign a non-disclosure agreement
                                         on reasonable terms to be agreed between the Auditor and Licensee in advance of the commencement
                                         of any audit.

 

		4.3.	Reporting and Use of Audit Results. The Auditor
is authorized to report to Wilson whether Licensee is or is not (and if not, in what manner) in compliance with its obligations
under this Agreement as well as the particulars of such non-compliance, if any. The auditor shall furnish Licensee with a copy
of all audit reports furnished to Wilson. Wilson shall use, the information resulting from such audits exclusively for the administration
and enforcement of this Agreement. The contents of any such audit report shall be treated by Wilson as Confidential Information
of Licensee.

 

		4.4.	Reconciliation. In the event that the audit identifies
an overpayment of Royalties by Licensee, Wilson will credit the amount overpaid to Licensee against the next payment due under
this Agreement. To the extent that no further payment is due under this Agreement, Wilson shall within sixty (60) days after such
determination, pay Licensee the amount by which Royalties were determined to be overpaid. In the event that the audit identifies
any underpayment of royalties by Licensee, then Licensee shall within thirty (30) days after such determination, pay Wilson the
shortfall plus any applicable interest. In the event that any underpayment for the audit period exceeds five percent (5%) of the
Royalty amount actually due, Licensee shall reimburse Wilson in full for the actual cost of the audit and related attorneys’
fees.

 

    	CONFIDENTIAL	Page 7

     

    

 

		5.	Term and Termination

 

		5.1.	Term. This
                                         Agreement shall come into force on the Agreement Date and shall remain in force until
                                         the last to expire of the Wilson Licensed Patents, unless earlier terminated as set forth
                                         in this Section 5 (“Term”).

 

		5.2.	Termination for Material Breach. After notice
and expiration of the cure period, a Party may terminate this Agreement by written notice if the other Party (or an Affiliate)
at any time commits a material breach of any of its significant obligations under this Agreement (which shall expressly include
any non-payment) and fails to provide a commercially reasonable cure to the noticed breach within sixty (60) days after receipt
of a notice specifying the nature of such breach and requiring remedy of the same. The Parties agree that the failure to identify
in this Agreement the breach of any particular obligation as a “material breach” does not preclude any Party from
contending in the future that such breach is “material.”

 

		5.3.	Challenge to Licensed Patents Deemed a Material Breach.
A material breach is deemed to have occurred if during the Term of this Agreement and not in response to a court order, subpoena,
administrative order or similar, Licensee institutes or actively participates as an adverse party in, or otherwise provides material
support to, any action, suit or other proceeding in the Territory to invalidate or limit the scope of any Wilson Licensed Patent
or obtain a ruling that any Wilson Licensed Patent is unenforceable or not patentable (“Licensed Patent Challenge”).

 

		5.4.	Corporate Events. A Party shall provide written
notice to the other Party immediately upon the occurrence of any of the following events: (i) its insolvency, bankruptcy or liquidation
or filing of any application therefor, or other commitment of an affirmative act of insolvency; (ii) attachment, execution or
seizure of substantially all of the assets of the notifying Party or filing of any application therefor; (iii) assignment or transfer
of that portion of the business to which this Agreement pertains to a trustee for the benefit of creditors; (iv) termination of
its business or dissolution; or (v) in the case of Licensee, within ninety (90) days after the closing of a merger, acquisition,
consolidation, transfer or otherwise wherein more than fifty percent (50%) of the ownership or control of Licensee is acquired
by an entity then engaged in the manufacture or sale of End User Devices and such acquiring entity was an adverse party to Wilson
in infringement or validity or damages, or similar litigation arising from one or more, Licensed Patents at the time of the acquisition
closing date. The other Party shall have the right to terminate this Agreement with immediate effect by giving written notice
of termination at any time upon such occurrence.

 

		5.5.	Effects of Termination. Upon any termination of
this Agreement, all licenses and rights granted hereunder shall be terminated, except that the Parties’ rights and obligations
under the following Sections of this Agreement shall survive in accordance with their terms: 1, 2.7, 4, 5, 7.1,
8.3, 8.4, 9, 10, 11, and 12.

 

    	CONFIDENTIAL	Page 8

     

    

 

		6.	Assignment and Transfer

 

		6.1.	Transfer of Licensed Patents. Nothing contained
herein shall prohibit Wilson from selling or assigning any Licensed Patent, provided that Wilson shall procure from its buyer
or assignee that any such sale or assignment of any such Licensed Patent shall be subject to the licenses, covenants and releases
granted to Licensee herein. If Wilson or any of its Affiliates transfers its business in whole or in part through divestiture,
merger or otherwise to a Third Party, Wilson shall procure, prior to the divestiture, that the license, covenant and release granted
to Licensee under this Agreement shall continue (as if no such divestiture occurs) for the Term.

 

		6.2.	Transfer of Licensees Rights and Obligations.
Subject to Section 5.4, Licensee may sell, assign, transfer or otherwise divest this Patent License Agreement and all its rights
and obligations hereunder in a transaction wherein more than fifty percent (50%) of the ownership or control of Licensee is acquired
by a single entity provided that the rights granted herein apply only to Signify branded products. The acquiring entity shall
be subject to the licenses, covenants and releases granted to Licensee herein and it shall be expressly understood that the rights
assigned and obligations delegated shall not extend beyond those possessed by Licensee at the time of the acquisition and shall
expressly exclude the acquiring entity’s business at the time of acquisition and thereafter.

 

		6.3.	No Other Assignment. Save as otherwise set out
herein, neither Party may grant or assign any rights or delegate any obligations under this Agreement to any Third Party (save
to an Affiliate) without the prior written consent of the other Party, and any attempted assignment without such consent shall
be null and void.

 

		7.	Representations,
                                         Warranties and Liability

 

		7.1.	Wilson. Wilson hereby represents and warrants
that (i) it has received all necessary corporate approvals and that the signatory below is duly authorized to execute this Agreement
on behalf of Wilson; (ii) Wilson and/or its Affiliates own, control or have the right to license the Wilson Licensed Patents on
the terms set forth herein; and (iii) it has not made and shall not make any agreements, assignments or encumbrances inconsistent
with the provisions of this Agreement.

 

		7.2.	Licensee. Licensee hereby represents and warrants
that (i) it has received all necessary corporate approvals and that the signatory below is duly authorized to execute this Agreement
on behalf of Licensee; (ii) it has not made and shall not make any outstanding agreements, assignments or encumbrances inconsistent
with the provisions of this Agreement; and (iii) the information that Licensee has provided to Wilson is true, accurate,
and complete.

 

    	CONFIDENTIAL	Page 9

     

    

 

		7.3.	General Disclaimers. Nothing contained in this
Agreement shall be construed as:

 

	 	(a)	a warranty or representation, either expressed or implied, as to the validity, enforceability or scope of any Wilson Licensed Patent herein;

 

	 	(b)	an agreement to bring or prosecute actions or suits against Third Parties for infringement;

 

	 	(c)	conferring any right to use, in advertising, publicity or otherwise, any name, trade name, trademark, or any contraction, abbreviation or simulation thereof of the other Party;

 

	 	(d)	a warranty or representation that the manufacture, sale, lease, use or importation of Licensed Products will be free from infringement of patents, copyrights or other intellectual property rights of Third Parties;

 

	 	(e)	an obligation to furnish any manufacturing or technical information or assistance;

 

		(f)	an obligation to file any patent application, or to secure
any patent or patent rights, or to maintain any patent in force, or to provide copies of patent applications to the other Party
or its Affiliates, or to disclose any inventions described or claimed in such patent applications; or

 

		(g)	an obligation upon either Party to make any determination
as to the applicability of any Patent to any product of the other Party.

 

		7.4.	EXPRESS DISCLAIMER. WILSON EXPRESSLY DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES,
                                                                                   WHETHER WRITTEN, ORAL, EXPRESS, IMPLIED, STATUTORY OR OTHERWISE, CONCERNING THE VALIDITY, ENFORCEABILITY AND SCOPE OF THE
                                                                                   WILSON LICENSED PATENTS, THE ACCURACY, COMPLETENESS, SAFETY, USEFULNESS FOR ANY PURPOSE OR, LIKELIHOOD OF SUCCESS
                                                                                   (COMMERCIAL, REGULATORY OR OTHER) OF THE LICENSED PRODUCTS, AND ANY TECHNICAL INFORMATION, TECHNIQUES, MATERIALS, METHODS,
                                                                                   PRODUCTS, PROCESSES OR PRACTICES AT ANY TIME MADE AVAILABLE BY LICENSOR INCLUDING ALL IMPLIED WARRANTIES OF MERCHANTABILITY,
                                                                                   QUALITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT AND WARRANTIES ARISING FROM A COURSE OF DEALING, COURSE OF
                                                                                   PERFORMANCE, USAGE OR TRADE PRACTICE, WITHOUT LIMITATION TO THE FOREGOING, WILSON SHALL HAVE NO LIABILITY WHATSOEVER TO
                                                                                   LICENSEE OR ANY OTHER PERSONS FOR OR ON ACCOUNT
OF ANY INJURY, LOSS OR DAMAGE, OF ANY KIND OR NATURE, SUSTAINED BY, OR ANY DAMAGE ASSESSED OR ASSERTED AGAINST, OR ANY OTHER LIABILITY
INCURRED BY OR IMPOSED ON LICENSEE OR ANY OTHER PERSON, ARISING OUT OF OR IN CONNECTION WITH OR RESULTING FROM (A) MANUFACTURE,
USE, OFFER FOR SALE, SALE, OR IMPORT OF A LICENSED PRODUCT, OR THE PRACTICE OF THE WILSON LICENSED PATENTS; (B) THE USE OF OR ANY
ERRORS OR OMISSIONS IN ANY KNOW-HOW, TECHNICAL INFORMATION, TECHNIQUES, OR PRACTICES DISCLOSED BY WILSON; OR (C) ANY ADVERTISING
OR OTHER PROMOTIONAL ACTIVITIES CONCERNING ANY OF THE FOREGOING.

 

    	CONFIDENTIAL	Page 10

     

    

 

		7.5.	Indemnification. Licensee agrees to indemnify
Wilson and its Affiliates against any and all out-of-pocket costs,
or damages arising out of or in connection with the manufacture, commercialization, marketing, sale or use of Licensed Products, including, but not limited to,
any actual or alleged injury, damage, death, liability or other consequence occurring to any legal or natural person or property
as a result, directly or indirectly, of the possession, use, manufacture, sale or import of any Licensed Products, claimed by reason
of breach of warranty, negligence, product defect, infringement of intellectual property rights (other than the Licensed Patents)
or other cause of action, regardless of the form in which any such claim is made. In the event of any such claim is brought, Wilson
shall promptly notify Licensee in writing of the claim and Licensee shall manage and control, at its sole expense, the defense
of the claim and its settlement. Wilson shall cooperate with Licensee and may, at Wilson’s option, be represented in any such action
or proceeding at its own expense.

 

		7.6.	Indemnification.

 

Wilson agrees to indemnify
Licensee and its Affiliates against any and all out o f- pocket costs, or damages arising out of or in connection with any
and all court or administrative proceedings involving a challenge to the validity or misuse of the Licensed Patents,
third-party infringement of the licensed patents, or the value of the Licensed Patents (hereinafter “Indemnified
Claims”). For the avoidance of doubt, Indemnified Claims do not include anything enumerated in Section 7.4 above.

 

In the event Licensee receives written
communication regarding any Indemnified Claims, Licensee shall promptly notify Wilson in writing of the communication and Wilson
shall manage and control, at its sole expense, the response to such communication as agreed by the Parties and any and all resulting
actions or agreements resulting therefrom. Licensee shall cooperate with Wilson and may, at Licensee’s option, be represented by
its own counsel in any such action or proceeding at its own expense.

 

    	CONFIDENTIAL	Page 11

     

    

 

		8.	Governing Law
                                         and Dispute Resolution

 

		8.1.	Governing Law. This Agreement, including, without
limitation, all matters relating to performance under this Agreement, shall be construed, interpreted, applied and governed in
all respects in accordance with the laws of the United States of America and the State of Utah without reference to its conflict
of laws principles.

 

		8.2.	Dispute Resolution. Any controversy, difference,
claim or other dispute arising out of or relating to this Agreement, including the validity, interpretation, performance, breach
or termination of this Agreement, or the amount of Royalties due hereunder, shall be referred to and finally resolved in the federal
or state courts of the State of Utah.

 

		8.3.	Injunctive Relief. Notwithstanding the foregoing,
either Party may seek interim or injunctive relief from any court of competent jurisdiction pending resolution of the controversy,
difference, claim or other dispute.

 

		9.	Notices

 

Any and all notices, requests,
demands, consents, agreements and other communications required or permitted to be given or made under this Agreement shall be
given in writing and in the English language and shall be (i) delivered personally; or (ii) sent by facsimile; or (iii) mailed
by registered mail; or (iv) delivered by courier to the following addresses of the Parties or to such other address as the Party
concerned may subsequently notify in writing to the other Party in accordance with this Section 10.

 

	 	If to Wilson:	Bruce Lancaster
	 	 	Wilson Electronics, LLC
	 	 	2890 E. Cottonwood Pkwy, #325 
	 	 	Cottonwood Heights, UT 84121
	 	 	 
	 	With Copy to:	Jed H. Hansen
	 	 	Thorpe North & Western, LLP
	 	 	175 South Main St. Suite 900
	 	 	Salt Lake City, Utah 84111
	 	 	 
	 	If to Licensee:	Signifi Mobile, Inc.
	 	 	Marc Seelenfreund, CEO
	 	 	1001 Rue Lenoir, Suite A-414
	 	 	Montreal, Quebec, H4C2Z6 
	 	 	Canada
	 	 	 
	 	With Copy to:	Craig M Carothers, Esq.
	 	 	16811 Holland Rd. 
	 	 	Pearland, TX 77584

 

    	CONFIDENTIAL	Page 12

     

    

 

Unless otherwise specifically
provided in this Agreement, such notice shall be deemed given: (i) if delivered personally or by courier, upon delivery; (ii) if
mailed by registered mail, unless actually received earlier, seven (7) days after the date of mailing; or (iii) on the day of the
receipt of sender’s facsimile confirmation of the transmission in case of facsimile.

 

		10.	Confidentiality

 

		10.1.	Confidential Information. For purposes of this
Agreement, “Confidential Information” means confidential, proprietary or secret information of a Party or its
Affiliates which is so designated by such Party in writing, whether by letter or by the use of a proprietary stamp or legend,
and which is disclosed by such Party to the other Party or its Affiliates hereunder. For the avoidance of doubt, the information
contained in Licensee’s Sales Reports shall constitute the Confidential Information of Licensee. The Parties entered into
a prior Confidentiality Agreement dated July 20, 2017, in an effort to facilitate discussions related to this Agreement. The Parties
agree and acknowledge that any and all Confidential Information as defined by this Agreement disclosed between the Parties after
the July 20, 2017, agreement but prior to the Effective Date of this Agreement shall be treated as Confidential Information as
if it was disclosed pursuant to this Agreement.

 

		10.2.	Restrictions. All Confidential Information disclosed
by a disclosing Party hereunder shall be held in strict confidence by the receiving Party and shall be used only in connection
with the performance of the receiving Party’s obligations or the exercise of its rights under this Agreement. Except as
expressly permitted herein, the receiving Party shall not, without the prior written consent of the disclosing Party, disclose
any such Confidential Information to any Third Party and the receiving Party shall take, all reasonably appropriate measures to
prevent the unauthorized disclosure of such Confidential Information. Notwithstanding the foregoing, each Party may disclose Confidential
Information of the other Party to its directors, officers, employees, Affiliates and agents in connection with its activities
pursuant to this Agreement. Each receiving Party shall ensure that each of the entities or persons to whom it discloses Confidential
Information of the other Party as permitted under this Section 10.1 is aware of the receiving Party’s duty of confidentiality
and non-use under this Agreement.

 

		10.3.	Exceptions. The confidentiality and non-use obligations
under this Section 10 shall not apply to any information that (a) is or becomes a part of the public domain through no wrongful
act or omission or breach of this Agreement on the part of the receiving Party, (b) is disclosed to the receiving Party by a Third
Party having no obligation of confidentiality with respect thereto, or (c) is independently developed by the receiving Party without
reference to the Proprietary Information of the disclosing Party. In addition, the receiving Party may disclose Proprietary Information
as required (but only to the extent required) to comply with applicable
laws, provided that the disclosing Party is given, if commercially reasonable, advance notice of such disclosure and, if commercially
reasonable, the opportunity to limit its scope or seek a protective order or other relief.

 

    	CONFIDENTIAL	Page 13

     

    

 

		10.4.	Terms of Agreement. Licensee acknowledges that
Wilson is committed to grant licenses under the Wilson Licensed Patents to Third Parties on terms that do not discriminate against
such Third Parties. Accordingly, Wilson shall be permitted to disclose the terms of this Agreement to any Third Party (including
its financial and legal representatives) with which Wilson is negotiating a license to the Wilson Licensed Patents, provided that
Wilson shall not disclose the name or other identifying information of Licensee when disclosing the terms of this Agreement. Notwithstanding
the foregoing, either Party may publicly disclose that Licensee has been granted a. license under the Wilson Licensed Patents
without further detail.

 

		11.	Miscellaneous

 

		11.1.	Waiver. Neither this Agreement nor any provision
hereof may be waived without the prior written consent of the Party against whom such waiver is asserted. No delay or omission
by either Party to exercise or assert any right or power shall impair any such right or power to be construed to be a waiver thereof.
Consent by either Party to, or waiver of, a breach by the other Party shall not constitute consent to, waiver of, or excuse for
any other different or subsequent breach.

 

		11.2.	Force Majeure. Neither Party shall be in default
or liable for any loss or damage resulting from delays in performance or from failure to perform or comply with terms of this
Agreement due to any unforeseeable, unavoidable and unpreventable causes, which causes include but are not limited to Acts of
God; riots and insurrections; natural catastrophe; social unrest; war; fire; and military action.

 

		11.3.	Entire Agreement. This Agreement, and its Appendices,
constitutes the entire and only agreement between the Parties with respect to the subject matter hereof and merges and supersedes
all prior and contemporaneous oral or written discussions, negotiations, understandings, representations, warranties and agreements
of the Parties.

 

		11.4.	Amendment. Any amendment or modification of any
of, the provisions of this Agreement or any right, power or remedy hereunder shall not be effective unless made in writing and
signed by duly authorized representatives of both Parties.

 

		11.5.	Drafting. This Agreement is considered to be jointly
drafted and neither Party shall benefit from who actually drafted the Agreement.

 

    	CONFIDENTIAL	Page 14

     

    

 

		11.6.	Severability. If any of the provisions of this
Agreement is or becomes invalid, illegal or unenforceable, the validity, legality, and enforceability of any other provision of
this Agreement shall in no way be affected or impaired thereby, and such invalid or unenforceable term, Section or provision shall
be deemed deleted from this Agreement, and this Agreement shall continue in full force and effect. Should such case arise, the
Parties shall negotiate in good faith a replacement but legally valid, term, Section or provision that best meets the intent of
the Parties.

 

		11.7.	Independent Contractors. The relationship between
Wilson and Licensee is that of independent contractors. Wilson and Licensee are not joint ventures, partners, principal and agent,
master and servant, employer or employee, and have no other relationship other than independent contracting parties. Each Party
is executing this Agreement solely on behalf of itself and its Affiliates and is not acting on behalf of, and does not represent,
any other company or entity or any government agency. Nothing in this Agreement shall be construed as creating a partnership,
joint venture, or other formal business organization of any kind.

 

		11.8.	Registration. Each Party agrees, upon reasonable
request by the other Party, to consent to the registration of this Agreement to the extent required by the laws of the applicable
jurisdiction requiring registration and subject always to the terms herein.

 

		11.9.	Counterparts. This Agreement may be executed in
counterparts and each such counterpart shall be deemed an original thereof. Facsimile signatures or signatures delivered by e-mail
in .pdf or similar format will be deemed original signatures for purposes of this Agreement.

 

		11.10.	Headings. The headings and sub-headings of the
Sections are inserted for convenience or reference only and are not intended to be a part of or to affect the meaning or interpretation
of this Agreement.

 

		11.11.	Construction. The words “hereof,”
“herein” and “hereunder” and words of like import when used in this Agreement shall refer to this Agreement
as a whole and not to any particular provision of this Agreement, and Section references are to this Agreement unless otherwise
specified. For the purpose of the construction and interpretation of this Agreement, the word “including” (and variations
thereof such as “include” and “includes”) and the phrase “such as” will not be deemed to be
terms of limitation, but rather will be deemed to be followed by the words “without limitation”.

 

[Remainder of page intentionally blank]

 

    	CONFIDENTIAL	Page 15

     

    

 

IN WITNESS WHEREOF, the Parties hereto have caused this
Agreement to be signed by their duly authorized representatives and executed on the Date.

 

	WILSON ELECTRONICS, LLC.	 	LICENSEE:	 
	 	 	 	 	 
	Name:	Bruce Lancaster	 	Name: 	Marc Seelenfreund
	Signature: 	/s/
    Bruce Lancaster	 	Signature:	/s/
    Marc Seelenfreund
	Date:	11/30/17	 	Date:	11/30/17

 

[Signature Page to Patent License Agreement]

 

    	CONFIDENTIAL	Page 16

     

    

 

APPENDIX A

 

WILSON LICENSED PATENTS

 

U.S. 7,409,186

 

U.S. 7,486,929

 

U.S. 7,221,967

 

U.S. 7,729,669

 

U.S. 7,783,318

 

U.S. 8,849,187

 

U.S. 8,538,033

 

U.S. 8,583,034

 

U.S. 8,639,180

 

U.S. 8,755,399

 

U.S. 8,874,029

 

U.S. 8,874,030

 

    	CONFIDENTIAL	Page 17

     

    

 

EXHIBIT B

 

LICENSED PRODUCTS

 

	SKU	 	Name
	2003CPAL	 	Uniden® U2 4G Cellular Booster
	003	 	Uniden® U2 Cellular Booster
	004	 	Uniden® U4 Cellular Booster
	2005CPAL	 	Uniden® U60 4G Cellular Booster
	005	 	Uniden® U60 Cellular Booster
	2005CP	 	Uniden® U60 Cellular Booster
	2005VCPAL	 	Uniden® U60v 4G Cellular Booster
	2006CPAL	 	Uniden® U65 4G Cellular Booster
	006	 	Uniden® U65 Cellular Booster
	2006CP	 	Uniden® U65 Cellular Booster
	2006VCPAL	 	Uniden® U65v 4G Cellular Booster
	2020CPALF	 	Uniden® U70 4G Cellular Booster
	020	 	Uniden® U70 Cellular Booster
	2020CP	 	Uniden® U70 Cellular Booster
	2020CPAL	 	Uniden® U70i 4G Cellular Booster
	2020VCPAL	 	Uniden® U70v 4G Cellular Booster
	2080CPAL	 	Uniden® U80i 4G Cellular Booster
	023	 	Uniden® UL20 Cellular Booster
	2021CPAL	 	Uniden® UM50 4G Cellular Booster
	021	 	Uniden® UM50 Cellular Booster
	2021CP	 	Uniden® UM50 Cellular Booster
	022	 	Uniden® UP20 Cellular Booster

 

 

	CONFIDENTIAL	Page 18Exhibit 10.4

 

SIYATA MOBILE INC.

 

 

 

 

INCENTIVE
STOCK OPTION PLAN

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Approved by the shareholders: June 17, 2015

 

Re-approved by the shareholders: September
16, 2016

 

     

    	 

    

 

SIYATA MOBILE INC.

 

STOCK OPTION PLAN

 

 

 

	1.	PURPOSE
                                         OF THE PLAN

 

The purpose of the
Plan is to provide Eligible Persons with an opportunity to purchase Shares and to benefit from the appreciation in the value of
the Shares. The Plan will provide an increased incentive for those individuals to contribute to the future growth, success and
prosperity of the Company, thus enhancing the value of the Shares for the benefit of all of the Company’s shareholders and increasing
the ability of the Company and any Affiliate to attract and retain skilled and motivated individuals.

 

	2.	INTERPRETATION

 

	2.1.	Definitions

 

In the Plan, the following terms shall have the following
meanings:

 

“Associate” means an associate as
defined in Exchange Policy 1.1 — Interpretation.

 

“Affiliate” has the meaning set out in the Corporations
Act;

 

“Blackout Period” means an interval
of time (i) when any trading guidelines of the Company, as amended from time to time, restrict Participants from trading in any
securities of the Company because they may be in possession of confidential information; or (ii) when the Company has determined
that one or more Participants may not trade any securities of the Company because they may be in possession of confidential information;

 

“Board” means the board of directors
of the Company and any committee of the board of directors to which any or all authority, rights, powers and discretion with respect
to the Plan has been delegated;

 

“Business Day” means a day that is
not a Saturday, Sunday or a statutory or public holiday and any other day on which the banks are not regularly open for business
in the jurisdiction where the Company has its head office;

 

“Cause” means any act, omission or
course of conduct recognized as cause under applicable law, including, without limitation, embezzlement, theft, fraud, wilful failure
to follow any lawful directive of the Company and wilful misconduct detrimental to the interests of the Company;

 

“Company” means Siyata Mobile Inc.
and its successors;

 

“Consultant” means a person,
company, partnership or other entity, other than an Employee, Officer or Director, that is engaged to provide on an ongoing
basis, consulting, technical, management or other services (other than services in relation to
a distribution) to the Company or an Affiliate of the Company under a written contract with the Company or an
Affiliate of the Company, and otherwise meets the definition of “consultant” contained in NI 45-106 and Exchange
Policy 4.4 — Incentive Stock Options, and includes, for an individual consultant, a company, partnership or
other entity of which the individual consultant is an employee, shareholder or partner;

 

     

    	 

    

 

“Corporations Act” means the British Columbia Business Corporations Act, as amended or
replaced from time to time;

 

“Director” means a director of the Company
or an Affiliate of the Company;

 

“Disability” means any disability with respect
to a Participant which the Board, in its sole and unfettered discretion, considers likely to permanently prevent the Participant
from:

 

		(a)	being employed or engaged by the Company, an Affiliate of the Company or another employer, in a position the same as or substantially
similar to that in which the Participant was last employed or engaged by the Company or an Affiliate of the Company;

 

		(b)	acting as a director or officer of the Company or an Affiliate of the Company or another company; or

 

		(c)	engaging in any substantial gainful activity by reason of any medically determinable mental or physical impairment that can
be expected to result in death or that has lasted or can be expected to last a continual period of not less than 12 months;

 

“Disinterested Shareholders” means the shareholders
of the Company, including holders of any non-voting and subordinate voting shares of the Company, but excluding:

 

		(a)	Insiders to whom Options may be issued under the Plan; and

 

		(b)	Associates of those Insiders;

 

“Discounted Market Price” means the “Market
Price” as defined in Exchange Policy 1.1 — Interpretation, less the allowable discount under the policies of
the Exchange;

 

“Eligible Person” means a bona
fide Director, Officer, Employee, Consultant, and any “permitted assign” within the meaning of NI 45-106;

 

“Employee” means an employee (whether
full-time or part-time) of the Company or an Affiliate of the Company within the meaning of Exchange Policy 4.4 — Incentive
Stock Options, or a Management Company Employee;

 

“Exchange” means the TSX Venture
Exchange or, if the Shares are not listed and posted for trading on the TSX Venture Exchange, the most senior stock exchange in
Canada on which the Shares are listed and posted for trading;

 

    2

    	 

    

 

“Exchange Hold Period” means the “Exchange
Hold Period” as defined in Exchange Policy 1.1 — Interpretation;

 

“Expiry Date” means the date set by the Board
under Section 3.1 of the Plan, as the last date on which an Option may be exercised by the Participant;

 

“Grant Date” means the date specified in an
Option Agreement as the date on which an Option is granted;

 

“Insider” means:

 

		(a)	an insider as defined in the Securities Act, other than a person who is an insider solely by virtue of being a director or
senior officer of an Affiliate; and

 

		(b)	an Associate of any person who is an insider under section (a);

 

“Investor Relations Activities” means investor
relations activities as defined in Exchange Policy 1.1 — Interpretation;

 

“Management Company Employee” means an individual
employed by a person providing management services to the Company which are required for the ongoing successful operation of the
business enterprise of the Company, but excludes a person engaged in Investor Relations Activities;

 

“NI 45-106” means Canadian National Instrument
45-106 — Prospectus and Registration Exemptions;

 

“Officer” means an executive officer (as that
term is defined in NI 45-106) of the Company or an Affiliate of the Company;

 

“Option” means an option to purchase Shares
granted pursuant to the Plan;

 

“Option Agreement” means an agreement, in the
form attached hereto as Schedule A, whereby the Company grants an Option to a Participant;

 

“Option Price” means the per Share exercise
price specified in an Option Agreement to be paid to acquire Option Shares, adjusted from time to time in accordance with the provisions
of Section 5;

 

“Option Shares” means the aggregate number
of Shares which a Participant may purchase under an Option;

 

“Participant” means an Eligible Person granted
an Option pursuant to the Plan and his or her heirs, executors and administrators and, subject to the policies of the Exchange,
a Participant may also be a company wholly-owned by an individual eligible for an Option grant pursuant to the Plan;

 

    3

    	 

    

 

“Plan” means this Siyata Mobile
Inc. Stock Option Plan, as amended from time to time in accordance with the provisions hereof;

 

“Securities Act” means the Securities
Act (British Columbia), as amended or replaced from time to time;

 

“Shares” means the Common Shares
in the capital of the Company as constituted on the date of the Plan provided that, in the event of any adjustment pursuant to
Section 5, “Shares” shall thereafter mean the shares or other property resulting from the events giving rise to the
adjustment;

 

“Unissued Option Shares” means the
number of Shares, at a particular time, which have been allotted for issuance upon the exercise of an Option but which have not
been issued, as adjusted from time to time in accordance with the provisions of Section 5, such adjustments to be cumulative;
and

 

“Vested” means that an Option has
become exercisable in respect of a number of Option Shares by the Participant pursuant to the terms of the Option Agreement and
the Plan.

 

	2.2.	Number and Gender

 

The Plan shall be read with all changes in number
and gender required by the context.

 

	2.3.	Sections

 

A reference to a Section includes all subsections
and paragraphs in that Section, unless the context otherwise requires.

 

	2.4.	Currency

 

Unless the context otherwise requires or the Board
determines otherwise, all references to currency shall be to the lawful money of Canada.

 

	3.	GRANT OF OPTIONS AND ADMINISTRATION OF
                                         THE PLAN

 

	3.1.	Option Terms

 

The Board may from time to time authorize the grant
of Options to Eligible Persons on the terms and subject to the conditions set out herein and any additional terms and conditions
as are set out in the Option Agreement, all as determined by the Board in its sole and unfettered discretion. Notwithstanding the
foregoing, if the Shares are, at the time of grant, listed and posted for trading on the Exchange:

 

		(a)	the Option Price under each Option shall be not less than
the Discounted Market Price on the Grant Date or such other minimum price as may be required by the Exchange;

 

		(b)	the Expiry Date for each Option shall be set by the Board at the time of issue of the Option and shall not be more than ten
years after the Grant Date, subject to extension in connection with a Blackout Period, as provided in Section 4.5; and

 

    4

    	 

    

 

		(c)	Options shall not be assignable or transferable by the Participant, except to the extent necessary to enable Options that have
Vested at the time of death of a Participant to be exercised by the legal personal representatives or beneficiary(ies) of the Participant
as contemplated in Section 4.4(a).

 

For greater certainty, the Board shall not be permitted
to amend the Option Price, and Options may not be re-priced, except as set out in Section 5 of the Plan 

   

	3.2.	Option Price at the Discounted Market Price

 

If required by the Exchange, the Option Price of an
Option is the Discounted Market Price, such Option shall be subject to the Exchange Hold Period and any Option Shares issued under
such Option prior to the expiry of the Exchange Hold Period shall be legended with the Exchange Hold Period commencing on the Grant
Date of such Option, as follows (or with such other legend as may be required by the Exchange):

  

“Without prior written approval of the Exchange
and compliance with all applicable securities legislation, the securities represented by this certificate may not be sold, transferred,
hypothecated or otherwise traded on or through the facilities of the TSX Venture Exchange or otherwise in Canada or to or for the
benefit of a Canadian resident until [insert the date immediately following the date which is four months after the Grant Date].”

 

	3.3.	Limits on Shares Issuable on Exercise of
                                         Options

 

Subject to Section 5.1,

 

		(a)	the maximum number of Shares that may be issuable pursuant to Options granted under the Plan shall be shall be a number equal
to 10% of the number of issued and outstanding Shares;

 

		(b)	unless approved by a majority of the Disinterested Shareholders,

 

		(i)	the aggregate number of Shares issuable pursuant to Options granted to Insiders pursuant to the Plan and all of the Company’s
other previously established and outstanding or proposed share compensation arrangements and grants may not exceed 10% of the issued
and outstanding Shares on a non-diluted basis at any time;

 

		(ii)	the aggregate number of Shares issued to Insiders pursuant to the Plan and all of the Company’s other previously established
and outstanding or proposed share compensation arrangements and grants within any 12 month period may not exceed 10% of the issued
and outstanding Shares on a non-diluted basis; and

 

    5

    	 

    

 

		(iii)	the aggregate number of Shares issuable to any one Participant
pursuant to the Plan and all of the Company’s other previously
established and outstanding or proposed share compensation arrangements and grants within any 12 month period may not exceed 5%
of the issued and outstanding Shares on a non-diluted basis;

 

		(c)	the aggregate number of Shares issuable pursuant to Options granted to any one Consultant pursuant to the Plan and all of the
Company’s other previously established and outstanding or proposed share compensation arrangements and grants within any 12 month
period may not exceed 2% of the issued and outstanding Shares on a non-diluted basis; and

 

		(d)	the aggregate number of Shares issuable pursuant to Options granted to all Participants performing Investor Relation Activities
pursuant to the Plan and all of the Company’s other previously established and outstanding or proposed share compensation arrangements
and grants within any 12 month period may not exceed 2% in aggregate of the issued and outstanding Shares on a non-diluted basis.

 

	3.4.	Option Agreements

 

Each Option will be evidenced by the execution of
an Option Agreement. Each Participant shall have the option to purchase from the Company the Option Shares at the time and in the
manner set out in the Plan and in the Option Agreement applicable to that Participant. In the case of Options granted to Employees,
Consultants or Management Company Employees, each Option Agreement will contain a representation of the Company and the Participant
that the Participant is a bona fide Employee, Consultant or Management Company Employee, as the case may be. The execution
of an Option Agreement shall constitute conclusive evidence that the grant of Options to the

Participant has been completed in compliance with
the Plan.

 

	3.5.	Authority of the Board

 

Subject only to the express provisions of the Plan,
the Board shall have, and hereby is specifically granted, the sole and unfettered authority to:

 

		(a)	grant Options to Eligible Persons;

 

		(b)	determine the terms, limitations, restrictions and conditions respecting Options;

 

		(c)	interpret the Plan and adopt, amend and rescind such administrative guidelines and other rules and regulations relating to
the Plan, as it may from time to time deem advisable;

 

		(d)	authorize any officer or director to execute and deliver any Option Agreement, notice, commitment or document and to do any
other act as contemplated by the Plan for and on behalf of the Company;

 

    6

    	 

    

 

		(e)	make all other determinations and perform all other actions as the Board deem necessary or advisable
to implement and administer the Plan; and

 

		(f)	subject to applicable law, delegate to the compensation committee or any other committee of the Board, on such terms as the
Board in its discretion determines, all or any part of the authority of the Board hereunder to administer and implement the Plan.

  

	3.6.	Discretion of the Board

 

The determinations of the Board under the Plan (including,
without limitation, determinations of who may receive grants of Options and the terms, limitations, restrictions and conditions
respecting Options) need not be uniform and may be made by the Board selectively among Eligible Persons who receive, or are eligible
to receive, grants of Options under the Plan, whether or not such Eligible Persons are similarly situated as to office, length
of service, salary or any other factor. The Board may, in its discretion, authorize the grant of additional Options to a Participant
before an existing Option has terminated.

 

	3.7.	Interpretation of the Plan

 

Except as set out in Section 5.4, the interpretation
and construction of any provision of the Plan by the Board shall be final and conclusive. Administration of the Plan shall be the
responsibility of the appropriate officers of the Company and the Company shall pay all costs in respect thereof. All guidelines,
rules, regulations, decisions and interpretations of the Board respecting the Plan, any Option Agreement or the Options shall be
binding and conclusive on the Company and on all Participants and their respective legal personal representatives.

 

	3.8.	Overriding Restrictions on Issue and Exercise

 

Notwithstanding anything else in this Plan or the
terms of any Option, no Option may be offered, issued or exercised if to do so:

 

		(a)	would contravene the constating documents of the Company, the Securities Act, the Corporations Act or any policy of the Exchange;
or

 

		(b)	would contravene the local laws or customs of a Participant’s country of residence or in the opinion of the Board would require
actions to comply with those local laws or customs which are impractical.

 

	4.	EXERCISE OF OPTIONS

 

	4.1.	When Options May be Exercised

 

Subject to this Section 4, an Option may be exercised
to purchase any number of Option Shares up to the number of Unissued Option Shares that have Vested at any time after the Grant
Date up to 5 p.m. in the location where the Company has its head office on the Expiry Date, provided the Expiry Date is a Business
Day and if the Expiry Date is not a Business Day, then the Expiry Date shall be deemed to fall on the next day that is a Business
Day, and shall not be exercisable thereafter.

 

    7

    	 

    

 

	4.2.	Manner of Exercise

 

The Options shall be exercisable by delivering, prior
to the Expiry Date, to the Company at its head office, a written notice specifying the number of Option Shares in respect of which
the Options are exercised together with payment in full of the Option Price for each such Option Share. All Option Shares subscribed
for upon exercise of the Options shall be paid in full at the time of subscription. No fractional Shares may be purchased or issued
hereunder.

 

	4.3.	Vesting of Options

 

With the exception of Options granted to a Consultant
who performs Investor Relations Activities, all Options granted to a Participant under the Plan will become vested on the Grant
Date, or at such other time as may be established by the Board at the time of the grant in compliance with requirements of the
Exchange. For Options granted to a Consultant who performs Investor Relations Activities, the Board will, at the time of grant,
determine the vesting date for such Options, provided that such Options must vest in stages over 12 months with no more than one-quarter
of the Options vesting in any three month period.

 

	4.4.	Termination of Employment or Affiliation

 

If a Participant ceases to be an Eligible Person,
the Participant’s Options shall be exercisable as follows:

 

		(a)	Death, Disability
                                         or Retirement. If the Participant ceases to be an Eligible Person due to his or her
                                         death, Disability or retirement in accordance with the Company’s retirement policy in
                                         force from time to time, or, in the case of a Participant that is a company, the death,
                                         Disability or retirement of the person who provides management or consulting services
                                         to the Company or to an Affiliate of the Company, the Options then held by the Participant
                                         shall be exercisable to acquire Unissued Option Shares that have Vested at the time of
                                         death, Disability or retirement at any time up to but not after the earlier of:

 

		(i)	365 days after the date of death, Disability or retirement;
and

 

		(ii)	the Expiry Date.

 

		(b)	Termination
                                         For Cause. If the Participant ceases to be an Eligible Person as a result of termination
                                         for Cause, any outstanding Options held by such Participant on the date of such termination,
                                         whether in respect of Option Shares that are Vested or not, shall be cancelled as of
                                         the date of delivery of written notice of termination (and specifically without regard
                                         to the date on which any period of reasonable notice, if any, would expire).

 

    8

    	 

    

 

		(c)	Early Retirement,
                                         Voluntary Resignation or Termination Other than For Cause. If the Participant ceases
                                         to be an Eligible Person due to the Participant’s retirement or, in the case of a Participant
                                         that is a company, the retirement of the person who provides management or consulting
                                         services to the Company or to an Affiliate of the Company, at the request of his or her
                                         employer earlier than the normal retirement date under the Company’s retirement policy
                                         then in force, or due to the Participant’s voluntary resignation or due to the termination
                                         of the Participant’s employment by the Company for reasons other than Cause, the Options
                                         then held by the Participant shall be exercisable, subject to section (d), to acquire
                                         Unissued Option Shares that have Vested at the time of retirement, resignation or termination
                                         for reasons other than Cause, at any time up to but not after the earlier of:

 

		(i)	the Expiry Date;

 

		(ii)	twelve months after the Participant ceases active employment or engagement with the Company or an Affiliate of the Company;
and

 

		(iii)	twelve months after the date of delivery of written notice of retirement, resignation or termination (and specifically without
regard to the date any period of reasonable notice, if any, would expire),

 

provided that the Board shall have the discretion to
increase the twelve-month period referred to in clause (ii) or (iii), above, as applicable, at any time for any period of time
up to the Expiry Date.

 

		(d)	For greater certainty, unless the Board determines otherwise,
an Option that had not become Vested in respect of any Unissued Option Shares at the time that the relevant events referred to
in Sections 4.4(a) or 4.4(c) occurred, shall not be or become exercisable in respect of such Unissued Option Shares and shall
be cancelled.

 

	4.5.	Blackout Periods

 

		(a)	No Option may be exercised during a Blackout Period.

 

		(b)	If the Expiry Date of an Option, or the deadline for exercising any Option set out in Section 4.4(a) or Section 4.4(c) falls
within a Blackout Period or within two Business Days after the expiry of a Blackout Period, such Expiry Date or deadline shall
be deemed to be extended by ten Business Days after the last day of the Blackout Period.

 

    9

    	 

    

 

	4.6.	Effect of a Take-Over
                                         Bid

 

Notwithstanding Section 4.3, if:

 

		(a)	a bona fide takeover
                                         offer (an “Offer”) is made to the shareholders of the Company to acquire
                                         their Shares and the Board becomes aware that more than 50% of the issued Shares have
                                         or will become vested in the offeror and related and associated parties, then the Board
                                         shall notify each Participant in writing that all Options issued to the Participant have
                                         become Vested and may be exercised by the Participant with effect from the date of such
                                         notice and shall be exercisable by a date specified in the notice. Upon receipt of such
                                         notice, the Participant shall be entitled to exercise all or any of the Options, and
                                         any Participant who exercises any such Options shall tender the Shares that have been
                                         issued as a result to the Offer. If for any reason if Shares are taken up and paid for
                                         by the offeror under the Offer as and when required, then the Shares that have been issued
                                         in pursuance of this paragraph (a) shall be returned by the relevant Participant to the
                                         Company and reinstated as authorized but Shares, the Option with respect to such returned
                                         Shares shall be reinstated as if it had not been exercised and the terms for the vesting
                                         of the Options shall be reinstated, and the Corporation shall immediately refund the
                                         exercise price paid for the issuance of any Shares upon the exercise of any Option under
                                         this paragraph (a) to the Option holder, without interest;

 

		(b)	the Board concludes that there has been such a change in
the control of issued Shares of the Company that the replacement of the majority of the Board is imminent or the Board becomes
aware that any person or corporation who is not already so entitled has become entitled to more than 50% of the issued Shares,
then the Board shall notify each Participant in writing that all Options issued to the Participant have become Vested and may
be exercised by the Participant with effect from the date of the notice and shall be exercisable by a date specified in the notice.
Upon receipt of such a notice, the Participant shall be entitled to exercise all or any of the Options.

 

		4.7.	Acceleration of Expiry Date

 

If at any time when an Option granted under the Plan
remains unexercised with respect to any Unissued Option Shares an Offer is made by an offeror, the Board may, upon notifying each
Participant of full particulars of the Offer, declare that all Options granted under the Plan have become Vested and accelerate
the Expiry Date for the exercise of all unexercised Options granted under the Plan so that all Options will either be exercised
or expire prior to the date upon which Shares must be tendered pursuant to the Offer.

 

	4.8.	Exclusion from Severance Allowance, Retirement
                                         Allowance or Termination Settlement

 

If the Participant retires, resigns or is terminated
from employment or engagement with the Company or an Affiliate, the loss or limitation, if any, pursuant to the Option Agreement
with respect to the right to purchase Option Shares which were not Vested at that time or which, if Vested, were cancelled, shall
not give rise to any right to damages and shall not be included in the calculation of nor form any part of any severance allowance,
retiring allowance or termination settlement of any kind whatsoever in respect of such Participant.

 

    10

    	 

    

 

	4.9.	Shares Not Acquired

 

Any Unissued Option Shares not acquired by a
Participant under an Option which have expired or have been cancelled may be made the subject of a further Option grant
pursuant to the provisions of the Plan.

 

	4.10.	Right to Participate in New Issues

 

To the extent that shareholders of the Company are
entitled to participate in new issues of Shares, a Participant, with respect to Vested Options held by such Participant, shall
not be entitled to participate in respect of such Vested Options, unless such Participant first exercises the Vested Options in
accordance with the terms of the Plan prior to the record date of such offering, whereby the Participant will be entitled to participation
by virtue of the Shares held by such Participant.

 

	4.11.	Quotation or Listing

 

		(a)	The Company will not seek the official quotation or listing of any Options.

 

		(b)	The Company will apply to the Exchange for official quotation or listing of Shares issued on the exercise of Options.

 

	5.	ADJUSTMENT OF OPTION PRICE AND NUMBER
                                         OF OPTION SHARES

 

	5.1.	Share Reorganization

 

If the Company issues Shares to all or substantially
all holders of Shares by way of a stock dividend or other distribution, or subdivides all outstanding Shares into a greater number
of Shares, or combines or consolidates all outstanding Shares into a lesser number of Shares (each of such events being a “Share
Reorganization”), then effective immediately after the effective date for such Share Reorganization for each Option:

 

	 	(a)	the Option Price will be adjusted to a price per Option
Share which is the product of:

 

		(i)	the Option Price in effect immediately before the effective date for the Share Reorganization; and

 

		(ii)	a fraction the numerator of which is the total number of Shares outstanding on the effective date of the Share Reorganization
before giving effect to the Share Reorganization, and the denominator of which is the total number of Shares that are or would
be outstanding on the effective date of the Share Reorganization after giving effect to the Share Reorganization; and

 

		(b)	the number of Unissued Option Shares will be adjusted by
multiplying (i) the number of Unissued Option Shares immediately before
the effective date of the Share Reorganization by (ii) a fraction which is the reciprocal of the fraction described in section 5.1(a)(ii). Subject to any provisions
with respect to rounding of entitlements as sanctioned by the meeting, if any, of shareholders approving a Share Reorganization,
in all other respects the terms for the exercise of Options shall remain unchanged notwithstanding the reorganization.

 

    11

    	 

    

  

	5.2.	Special Distribution

 

Subject to the prior approval of the Exchange if
the Company is listed on the Exchange at the relevant time, if the Company issues by way of a dividend or otherwise distributes
to all or substantially all holders of Shares:

 

		(a)	shares of the Company, other than Shares;

 

		(b)	evidences of indebtedness;

 

		(c)	any cash or other assets, excluding cash dividends (other than cash dividends which the Board has determined to be outside
the normal course); or

 

		(d)	rights, options or warrants,

 

then to the extent that such dividend or distribution
does not constitute a Share Reorganization (any of such non-excluded events being a “Special Distribution”), and
effective immediately after the record date at which holders of Shares are determined for purposes of the Special Distribution,
for each Option the Option Price will be reduced, and the number of Unissued Option Shares will be correspondingly increased, by
such amount, if any, as is determined by the Board in its sole and unfettered discretion to be appropriate in order to properly
reflect any diminution in value of the Shares as a result of such Special Distribution.

 

	5.3.	Corporate
                                         Reorganization

 

Whenever there is:

 

		(a)	a reclassification of outstanding Shares, a change of Shares into other shares or securities, or any other capital reorganization
of the Company, other than as described in sections 5.1 or 5.2;

 

		(b)	a consolidation, merger or amalgamation of the Company with or into another Company resulting in a reclassification of outstanding
Shares into other shares or securities or a change of Shares into other shares or securities; or

 

		(c)	a transaction whereby all or substantially all of the Company’s undertaking and assets become the property of another Company,

 

(any such event being a “Corporate Reorganization”)

 

the Participant will have an option to purchase (at
the times, for the consideration and subject to the terms and conditions set out in the Plan and the Option Agreement) and will
accept on the exercise of such option, in lieu of the Unissued Option Shares which the Participant would otherwise have been entitled
to purchase, the kind and amount of shares or other securities or property that the Participant would have been entitled to receive
as a result of the Corporate Reorganization if, on the effective date thereof, the Participant had been the holder of all Unissued
Option Shares or, if appropriate, as otherwise determined by the Board.

 

    12

    	 

    

 

	5.4.	Determination of Option Price and Number
                                         of Unissued Option Shares

 

If any questions arise at any time with respect to
the Option Price or number of Unissued Option Shares deliverable upon exercise of an Option following a Share Reorganization, Special
Distribution or Corporate Reorganization, such questions shall be conclusively determined by the Board in its sole and unfettered
discretion, and in arriving at a decision, the Board may consult such professional advisors as it deems necessary.

 

	5.5.	Compliance with Regulatory Authorities

 

Notwithstanding Sections 5.1, 5.2 or 5.3, in the
event of any reorganization (including, without limitation, consolidation, sub-division, reduction or return of the issued capital
of the Company) on or prior to the Expiry Date, the rights of the Participant will be changed to the extent necessary at the time
of such reorganization, in such manner as determined by the Board, to ensure compliance with the policies of the Exchange that
apply to a reorganization of capital at the time of such reorganization. For greater certainty, any adjustment to the Option Price
or the number of Unissued Option Shares purchasable under the Plan pursuant to the operation of any one of Sections 5.1, 5.2 or
5.3 is subject to the approval of the Exchange, if applicable, and any other governmental authority having jurisdiction.

 

	6.	MISCELLANEOUS

 

	6.1.	No Right to Employment

 

Neither the Plan nor any of the provisions hereof
shall confer upon any Participant any right with respect to employment, engagement or appointment or continued employment, engagement
or appointment with the Company or any Affiliate or interfere in any way with the right of the Company or any Affiliate to terminate
such employment, engagement or appointment.

 

	6.2.	Related Rights and Other Benefit Plans

 

No Participant shall have any of the rights of a
shareholder of the Company with respect to any Option Shares (including, without limitation, voting rights or any right to receive
dividends, warrants or rights under any rights offering) until the Participant has made full payment to the Company upon exercise
of the Option and such Option Shares have been issued to such Participant. Participation in the Plan shall not affect an Eligible
Person’s eligibility to participate in any other benefit plan or incentive plan of the Company. The grant of any Option pursuant
to the Plan shall not obligate the Company to make any benefit available to an Eligible Person under any other plan of the Company
unless otherwise specifically provided for in such plan.

 

    13

    	 

    

 

	6.3.	Necessary Approvals

 

If required by the Exchange, the Plan shall be subject
to the approval of the shareholders of the Company at each annual general meeting of the Company. The obligation of the Company
to sell and deliver Option Shares in accordance with the Plan is subject to the approval of the Exchange, if applicable, and any
other regulatory body having authority over the Company, the Plan or the shareholders of the Company. If any Option Shares cannot
be issued to any Participant for any reason, including, without limitation, the failure to obtain such approval, then the obligation
of the Company to issue such Option Shares shall terminate and the Company shall immediately refund to the Participant any Option
Price paid by the Participant to the Company.

 

	6.4.	Income Taxes

 

As a condition of and prior to participation in the Plan, each Participant authorizes
the Company to withhold from any amount otherwise payable to the Participant any amounts required by any taxing authority to be
withheld for taxes of any kind as a consequence of the Participant’s participation in the Plan or issuance of Option Shares. The
Company may, prior to and as a condition of issuing any Option Shares, require the Participant to pay to the Company in cash or
such other consideration as the Board, in its discretion, may accept, such amount as the Company is obliged to remit in accordance
with applicable tax laws and the requirements of any taxing authority having jurisdiction in respect of any such issuance of Option
Shares. The Company shall also have the right in its sole discretion to satisfy any such liability for withholding or other required
deduction amounts to require the Participant to complete a sale in respect of such number of Option Shares that have been issued
and would otherwise be delivered to the Participant under the Plan, and any amount payable from such sale will first be paid to
the Company to satisfy any liability for withholding. The Company may require a Participant, as a condition of participation in
the Plan, to pay or reimburse the Company for any cost incurred by the Company as a result of the participation by the Participant
in the Plan.

 

	6.5.	Amendments to the Plan

 

		(a)	The Board may from time to time, subject to applicable law and to the prior approval, if required, of the Exchange or any other
regulatory body having authority over the Company, the Plan or the shareholders of the Company, suspend, terminate or discontinue
the Plan at any time.

 

		(b)	The Board may amend or revise the terms of the Plan or of any Option granted under the Plan and the Option Agreement relating
thereto at any time without the consent of the Participants provided that such amendment shall:

 

		(i)	not adversely alter or impair any Option previously granted
except as permitted by the adjustment provisions of Section 5;

 

    14

    	 

    

  

		(ii)	be subject to any regulatory approvals including, where required, the approval of the Exchange; and

 

		(iii)	be subject to shareholder approval where required by law or the requirements of the Exchange, provided that shareholder approval
shall not be required for the following amendments and the Board may make any changes which may include but are not limited to:

 

		A.	amendments of a typographical, grammatical, clerical or administrative nature or which are required to comply with regulatory
requirements;

 

		B.	a change to the vesting provisions of the Plan or any Option;

 

		C.	a change to the termination provisions of any Option that does not entail an extension beyond the original Expiry Date (as
such date may be extended by virtue of Section 4.5); and

 

		D.	a change to the Eligible Persons of the Plan.

 

		(c)	Notwithstanding this Section 6.5, the Board shall not be permitted to amend the Option Price except as set out in Section 5.
If the Plan is terminated, the provisions of the Plan and any administrative guidelines and other rules and regulations adopted
by the Board and in force on the date of termination will continue in effect as long as any Option or any rights pursuant thereto
remain outstanding and, notwithstanding the termination of the Plan, the Board shall remain able to make such amendments to the
Plan or the Options as they would have been entitled to make if the Plan were still in effect.

 

		(d)	Without obtaining the prior approval of the shareholders of the Company and of the Exchange or any other regulatory body having
authority over the Company, the Board will not be entitled to:

 

		(i)	increase the maximum percentage of Shares issuable by the Company pursuant to the Plan;

 

		(ii)	extend the Expiry Date;

 

		(iii)	make a change to the class of eligible participants which would have the potential of broadening or increasing participation
by Insiders;

 

		(iv)	provide any form of financial assistance to Participants for the purchase of Option Shares; or

 

		(v)	add a deferred or restricted share unit or any other provision which results in a Participant receiving Shares

                                                                                when no cash consideration is received by the Company.

                                                                                

 

    15

    	 

    

 

		(e)	Without obtaining the prior
approval of the Disinterested Shareholders and of the Exchange or any other regulatory body having authority
over the Company, the Board will not be entitled to amend the terms of Options held by an Insider (including, for greater certainty,
to effectively reduce the Option Price).

 

	6.6.	Form of Notice

 

Any notice to be given to the Company pursuant to
the provisions of the Plan shall be addressed to the Company to the attention of its President at the Company’s head office, and
any notice to be given to a Participant shall be delivered personally or addressed to the Participant at the address set out in
the Option Agreement, or at such other address as such Participant may hereafter designate in writing to the Company. Any such
notice shall be deemed duly given when made in writing and delivered to the Company or the Participant, as the case may be, or
if mailed, then on the fifth business day following the date of mailing such notice in a properly sealed envelope addressed as
aforesaid, registered or certified mail, postage prepaid.

 

	6.7.	No Representation or Warranty

 

The Company makes no representation or warranty as
to the future market value of the Shares or with respect to any income tax matters affecting the Participant resulting from the
grant or exercise of an Option and/or transactions in the Option Shares. Neither the Company, nor any of its directors, officers
or employees are liable for anything done or omitted to be done by such person or any other person with respect to the price, time,
quantity or other conditions and circumstances of the purchase or sale of Option Shares hereunder, with respect to any fluctuations
in the market price of Shares or in any other manner related to the Plan.

 

	6.8.	Compliance with Applicable Law

 

If any provision of the Plan or any Option Agreement
contravenes any law applicable or any order, policy, by-law or regulation of the Exchange or any other regulatory body having authority
over the Company, the Plan or the shareholders of the Company, then such provision shall be deemed to be amended to the extent
required to bring such provision into compliance therewith.

 

	6.9.	No Assignment

 

No Option shall be assignable
or transferable by the Participant and any purported assignment or transfer of an Option shall be void and shall render the Option
void, provided that in the event of death of the Participant, a Participant’s legal personal representative may exercise the Option
in accordance with Section 4.4.

 

	6.10.	Other Incentive Schemes

 

The Company is not restricted to using the Plan
as the only method of providing incentive rewards to Eligible Persons. The Company may approve
other incentive schemes. Participation in the Plan does not affect, and is not affected by, participation in any other
incentive or other scheme of the Company unless the terms of that incentive or scheme provide otherwise.

 

    16

    	 

    

  

	6.11 .	Conflict

 

In the event of any conflict between the provisions
of the Plan and an Option Agreement, the provisions of the Plan shall govern.

 

	6.12.	Governing Law

 

The laws of the Province of British Columbia shall
govern the Plan and each Option Agreement issued pursuant to the Plan.

 

	6.13.	Time of Essence

 

Time is of the essence of the Plan and of each Option
Agreement. No extension of time will be deemed to be, or to operate as, a waiver that time is to be of the essence.

 

	6.14.	Entire Agreement

 

The Plan and the Option Agreement sets out the entire
agreement between the Company and the Participants relative to the subject matter hereof and supersedes all prior agreements, undertakings
and understandings, whether oral or written.

 

 

17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}]]